cd 437 has been researched along with Multiple Myeloma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Formstecher, P; Joseph, B; Lefebvre, O; Marchetti, P; Méreau-Richard, C; Schraen-Maschke, S | 1 |
1 other study(ies) available for cd 437 and Multiple Myeloma
Article | Year |
---|---|
The novel retinoid AHPN/CD437 induces a rapid but incomplete apoptotic response in human myeloma cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Survival; Fluorescent Antibody Technique, Indirect; Humans; Lamin Type B; Multiple Myeloma; Retinoids; RNA, Messenger; Transglutaminases; Tretinoin; Tumor Cells, Cultured; Ultrasonography | 2003 |